{
    "title": "A bill to amend title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable medical devices.",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Transparency in Medical Device \nPricing Act of 2007''.\n\nSEC. 2. REPORTING OF SALES PRICE DATA FOR IMPLANTABLE MEDICAL DEVICES.\n\n    Title XVIII of the Social Security Act (42 U.S.C. 1395 et seq.) is \namended by adding at the end the following new section:\n\n``SEC. 1898. REPORTING OF SALES PRICE DATA FOR IMPLANTABLE MEDICAL \n              DEVICES.\n\n    ``(a) Collection of Sales Price Data.--\n            ``(1) Quarterly reports from manufacturers of covered \n        medical devices.--Not later than the date that is 30 days after \n        the last day of each fiscal year quarter beginning on or after \n        January 1, 2009, in the case of a covered medical device that \n        is used in a procedure identified under subsection (b), each \n        manufacturer of such device shall submit to the Secretary, in \n        such form as the Secretary shall require, the following:\n                    ``(A) The name of the manufacturer of the covered \n                medical device.\n                    ``(B) The name of the covered medical device.\n                    ``(C) The category type of the covered medical \n                device (using a nomenclature specified by the Secretary \n                for categorizing medical devices in order to ensure \n                consistent reporting).\n                    ``(D) The hospital inpatient procedure or hospital \n                outpatient procedure identified under subsection (b) \n                with respect to which the medical device was used \n                during the quarter.\n                    ``(E) The average and median sales price of the \n                covered medical device.\n                    ``(F) Such other information as the Secretary \n                requires, including the unit of measure used to \n                determine the number of medical devices sold by the \n                manufacturer.\n            ``(2) Penalties for noncompliance.--\n                    ``(A) Failure to submit information.--Any \n                manufacturer of a covered medical device that fails to \n                submit information required under paragraph (1) in \n                accordance with regulations promulgated to carry out \n                such paragraph, shall be subject to a civil money \n                penalty of not less than $10,000, but not more than \n                $100,000, for each such failure.\n                    ``(B) Misrepresentation.--Any manufacturer of a \n                covered medical device that misrepresents the average \n                or median sales price of such device in information \n                submitted under paragraph (1) shall be subject to a \n                civil money penalty of not less than $10,000, but not \n                more than $100,000, for each such misrepresentation and \n                for each day in which such misrepresented average or \n                median sales price is made publicly available under \n                subsection (c).\n                    ``(C) Imposition and collection.--A penalty under \n                subparagraph (A) or (B) shall be imposed and collected \n                in the same manner as civil money penalties under \n                subsection (a) of section 1128A are imposed and \n                collected under that section.\n            ``(3) Definitions.--In this section:\n                    ``(A) Average sales price.--\n                            ``(i) In general.--Subject to clauses (ii) \n                        and (iii), the term `average sales price' \n                        means, of a covered medical device for a fiscal \n                        year quarter for a manufacturer for a unit--\n                                    ``(I) the manufacturer's sales to \n                                all purchasers (excluding sales \n                                exempted in clause (ii)) in the United \n                                States for such covered medical device \n                                in the quarter; divided by\n                                    ``(II) the total number of such \n                                units of such covered medical device \n                                sold by the manufacturer in such \n                                quarter.\n                            ``(ii) Certain sales exempted from \n                        computation.--In calculating the manufacturer's \n                        average sales price under this subparagraph, \n                        certain sales may be excluded in the case where \n                        the Secretary determines such exclusion is \n                        appropriate.\n                            ``(iii) Sale price net of discounts.--In \n                        calculating the manufacturer's average sales \n                        price under this subparagraph, such price shall \n                        include volume discounts, cash discounts, free \n                        goods and services that are contingent on any \n                        purchase requirement, chargebacks, and rebates, \n                        and any other discounts or price concessions \n                        the Secretary determines to be appropriate \n                        (using a methodology developed by the Secretary \n                        to estimate costs during the quarter that are \n                        attributable to discounts and price \n                        concessions).\n                    ``(B) Covered medical device.--The term `covered \n                medical device' means any device for which payment is \n                available under title XVIII or a State plan under title \n                XIX or XXI (or a waiver of such a plan).\n                    ``(C) Median sales price.--\n                            ``(i) In general.--Subject to clauses (ii) \n                        and (iii), the term `median sales price' means, \n                        of a covered medical device for a fiscal year \n                        quarter for a manufacturer for a unit, the \n                        median of all sales by the manufacturer to \n                        purchasers (excluding sales exempted in clause \n                        (ii)) in the United States for such covered \n                        medical device in the quarter.\n                            ``(ii) Certain sales exempted from \n                        computation.--In calculating the manufacturer's \n                        median sales price under this subparagraph, \n                        certain sales may be excluded in the case where \n                        the Secretary determines such exclusion is \n                        appropriate.\n                            ``(iii) Sale price net of discounts.--In \n                        calculating the manufacturer's median sales \n                        price under this subparagraph, such price shall \n                        include volume discounts, cash discounts, free \n                        goods and services that are contingent on any \n                        purchase requirement, chargebacks, and rebates, \n                        and any other discounts or price concessions \n                        the Secretary determines to be appropriate \n                        (using a methodology developed by the Secretary \n                        to estimate costs during the quarter that are \n                        attributable to discounts and price \n                        concessions).\n    ``(b) Identification of Procedures.--For purposes of subsection \n(a), the Secretary shall identify--\n            ``(1) all hospital inpatient procedures for which payment \n        is provided under section 1886(d) that involve the implantation \n        of a medical device; and\n            ``(2) all hospital outpatient procedures for which payment \n        is provided under section 1833(t) that involve the implantation \n        of a medical device.\n    ``(c) Public Availability.--Not later than April 30, 2009, the \nSecretary shall establish procedures to ensure that the information \nreported under subsection (a) is readily accessible to the public \nthrough the Internet website of the Centers for Medicare & Medicaid \nServices in a manner that is easily searchable, downloadable, and \nunderstandable. Such procedures shall ensure that the website is \nupdated each quarter as new information is reported under such \nsubsection.''."
}